Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. Selinexor (KPT-330)

   Karyopharm Therapeutics Inc

   Squamous Cell Carcinoma

   phase 2 · small molecule · terminated

   1 trial →

2. Selinexor 100 mg

   Karyopharm Therapeutics Inc

   Non-Small Cell Lung Carcinoma (NSCLC)

   phase 2 · small molecule · completed

   1 trial →

3. Selpercatinib

   Eli Lilly and Company

   Medullary Thyroid Cancer

   phase 2 · small molecule · active

   1 trial →

4. Selpercatinib Monotherapy

   United Therapeutics Europe Ltd

   Differentiated Thyroid Cancer

   phase 2 · small molecule · active

   1 trial →

5. Selumetinib

   United Therapeutics Europe Ltd

   Metastatic Thyroid Gland Carcinoma

   phase 2 · small molecule · completed

   1 trial →

6. Selumetinib

   United Therapeutics Europe Ltd

   Malignant Peripheral Nerve Sheath Tumors

   phase 2 · small molecule · completed

   1 trial →

7. Serplulimab

   The First People's Hospital of Lianyungang

   HER2-positive Gastric Cancer

   phase 2 · small molecule · active

   1 trial →

8. Serplulimab

   The First People's Hospital of Lianyungang

   Gastric Cancer

   phase 2 · small molecule · active

   1 trial →

9. Serplulimab

   The First People's Hospital of Lianyungang

   Colorectal Cancer (Diagnosis)

   phase 2 · small molecule · active

   1 trial →

10. Sigvotatug vedotin, PF-08634404

    Pfizer Australia Pty Ltd

    Advanced Solid Tumors

    phase 2 · small molecule · active

    1 trial →

11. Sindillimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small Cell Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

12. Sintilimab

    The First People's Hospital of Lianyungang

    Carcinoma

    phase 2 · mab · active

    1 trial →

13. Sintilimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Neoplasms

    phase 2 · small molecule · active

    1 trial →

14. Sintilimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Renal Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

15. Sintilimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small Cell Lung Cancer Stage III

    phase 2 · small molecule · active

    1 trial →

16. Sintilimab

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

17. Sintilimab

    The First People's Hospital of Lianyungang

    Multiple Primary Lung Cancer

    phase 2 · small molecule · active

    1 trial →

18. Sintilimab

    The First People's Hospital of Lianyungang

    Small Cell Lung Cancer Limited Stage

    phase 2 · small molecule · active

    1 trial →

19. Sintilimab

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma (NPC)

    phase 2 · small molecule · active

    1 trial →

20. Sintilimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

21. Sintilimab

    The First People's Hospital of Lianyungang

    Ovarian Clear Cell Carcinoma

    phase 2 · small molecule · completed

    1 trial →

22. Sintilimab (approved)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma (HCC)

    phase 2 · small molecule · active

    1 trial →

23. Sintilimab Combined with Platinum-containing Chemotherapy

    The First People's Hospital of Lianyungang

    Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

24. Sintilimab in combination with Multimodality Radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 2 · small molecule · active

    1 trial →

25. Sintilimab injection plus Inlyta treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carcinoma, Renal Cell

    phase 2 · small molecule · active

    1 trial →

26. Sintilimab with Interleukin-2+CAPOX

    The First People's Hospital of Lianyungang

    Locally Advanced Rectal Adenocarcinoma

    phase 2 · small molecule · completed

    1 trial →

27. Sintilimab,nab-paclitaxel and tegio

    The First People's Hospital of Lianyungang

    Gastric Cancer

    phase 2 · small molecule · active

    1 trial →

28. Sitravatinib

    BeiGene

    Carcinoma, Hepatocellular

    phase 2 · small molecule · completed

    1 trial →

29. Sm-EDTMP

    Jazz Pharmaceuticals Ireland Limited

    Metastatic Osteosarcoma

    phase 2 · small molecule · terminated

    1 trial →

30. Sodium Cridanimod

    Xenetic Biosciences

    Endometrial Cancer

    phase 2 · small molecule · terminated

    1 trial →

31. Sorafenib

    United Therapeutics Europe Ltd

    Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

32. Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin

    Bayer HealthCare AG

    Carcinoma, Hepatocellular

    phase 2 · small molecule · completed

    1 trial →

33. Steroids switch

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 2 · small molecule · completed

    1 trial →

34. Stivarga 40 mg film-coated tablets

    Ningbo Cancer Hospital

    Bone sarcoma

    phase 2 · small molecule · active

    1 trial →

35. Streptococcus salivarius K12

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Head and Neck Squamous Cell Carcinoma

    phase 2 · small molecule · completed

    1 trial →

36. Sunvozertinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Potentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

37. Sunvozertinib, Sunvozertinib

    Lacuna Pharma Pty Ltd

    Non-Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

38. Surufatinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Biliary Tract Cancer

    phase 2 · small molecule · active

    1 trial →

39. Surufatinib + Serplulimab+Albumin-paclitaxel + Gemcitabine

    Sun Yat-sen University

    Locally Advanced Pancreatic Cancer

    phase 2 · small molecule · active

    1 trial →

40. Surzebiclimab

    BeiGene

    Locally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-in

    phase 2 · small molecule · completed

    1 trial →

41. Surzebiclimab

    BEONE MEDICINES AUS PTY LTD

    Locally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-in

    phase 2 · small molecule · completed

    1 trial →

42. Systemic chemotherapy (FOLFIRI)

    The First People's Hospital of Lianyungang

    Rectum Cancer

    phase 2 · small molecule · completed

    1 trial →

43. T2214

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Diffuse Large B-cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

44. TACE and HAIC Combined With Regorafenib

    The First People's Hospital of Lianyungang

    Liver Metastasis Colon Cancer

    phase 2 · other · completed

    1 trial →

45. TAK-007

    Takeda

    Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

    phase 2 · mab · active

    1 trial →

46. TAK-186

    Takeda

    Squamous Cell Cancer of Head and Neck (SCCHN)

    phase 2 · small molecule · terminated

    1 trial →

47. TAK-188

    Takeda

    Advanced or Metastatic Solid Tumors

    phase 2 · small molecule · active

    1 trial →

48. TAK-280

    Takeda

    Unresectable Locally Advanced or Metastatic Cancer

    phase 2 · small molecule · terminated

    1 trial →

Frequently asked questions